DEFA14A: Protalix BioTherapeutics Announces Change of Location for 2024 Annual Meeting

Protalix BioTherapeutics has changed the location of its 2024 Annual Meeting of Stockholders, while the date and time remain the same.

Summary

• Protalix BioTherapeutics, Inc. has announced a change in the location for its 2024 Annual Meeting of Stockholders.
• The meeting will still be held on June 27, 2024, at 11:30 A.M. EDT.
• The new location is the offices of LifeSci Advisors, 250 W. 55th Street, Suite 3401, New York, NY 10019.
• The items of business to be addressed at the Annual Meeting remain unchanged as described in the previously distributed proxy materials.
• Stockholders can access proxy materials and vote their shares as described in the previously filed proxy materials.

Sentiment

Score: 7

Explanation: The document is a neutral announcement regarding a logistical change for the annual meeting, indicating standard corporate procedure.

Positives

• The announcement ensures stockholders are informed about the change in location for the Annual Meeting.

Risks

• Potential delays at the entrance to the meeting venue are anticipated, requiring attendees to arrive early.

Future Outlook

The document does not contain any specific forward-looking statements beyond the details of the Annual Meeting.

Industry Context

This announcement is a routine update related to corporate governance and shareholder engagement, common for publicly traded companies.

Stakeholder Impact

• Shareholders are directly impacted by the change in meeting location, requiring them to adjust their attendance plans if they intend to attend in person.

Next Steps

• Stockholders should refer to the proxy statement for information regarding the matters to be acted upon at the Annual Meeting.
• Stockholders planning to attend in person should arrive early due to potential delays at the entrance.

Key Dates

Keywords

Annual Meeting, Stockholders, Protalix BioTherapeutics, Location Change, Proxy Statement